UBS MSCI USA hedged to CHF UCITS ETF (CHF) A-acc is a equity ETF from UBS tracking the MSCI USA to index through physical replication. Domiciled in Ireland and launched in 2013, the fund manages about 585 M € and charges a TER of 0.10% — 10 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
UBS MSCI USA hedged to CHF UCITS ETF (CHF) A-acc competes with 2 other products on the same index (MSCI USA to): it ranks 2nd by fund size and 1st by ongoing cost, with a TER of 0.10% against a group median of 0.10%. It has been listed since 2013, 13 years of track record — the oldest in its comparison group.
On a €10,000 investment the TER costs 10 € a year. The cheapest of the group is UBS MSCI USA hedged to EUR UCITS ETF (EUR) A-acc at 0.10%, or 10 € on the same amount: a difference of 0 € every year, roughly 0 € over ten years before compounding.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 36.7% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in CHF and is a currency-hedged share class: the hedge aims to neutralise the effect of the underlying currencies against the reference currency, at an implicit cost that varies with interest-rate differentials.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| NVIDIA Corporation | 7.4% |
| Apple Inc. | 6.8% |
| Microsoft Corporation | 4.2% |
| Amazon.com Inc | 3.7% |
| Alphabet Inc Class A | 3.3% |
| Broadcom Inc | 2.7% |
| Alphabet Inc Class C | 2.6% |
| Micron Technology Inc | 2.1% |
| Meta Platforms Inc. | 2.0% |
| Tesla Inc | 1.9% |
| SIX Swiss Exchange | USCHWH | CHF |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.